Cargando…

SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice

BACKGROUND: In non-alcoholic steatohepatitis (NASH), muscle wasting was an aggravating factor for the progression of hepatic steatosis. This study explores the potential benefits of chronic treatment with resveratrol, a strong activator of SIRT1 on the muscle wasting of NASH mice. METHODS: In vivo a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chih-Wei, Huang, Chia-Chang, Hsu, Chien-Fu, Li, Tzu-Hao, Tsai, Yu-Lien, Lin, Ming-Wei, Tsai, Hung-Cheng, Huang, Shiang-Fen, Yang, Ying-Ying, Hsieh, Yun-Cheng, Lee, Tzung-Yan, Tsai, Chang-Youh, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228468/ https://www.ncbi.nlm.nih.gov/pubmed/32371503 http://dx.doi.org/10.1136/bmjgast-2020-000381

Ejemplares similares

Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
por: Tsai, Hung-Cheng, et al.
Publicado: (2019)

Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study
por: Li, Tzu-Hao, et al.
Publicado: (2021)

Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis
por: Li, Tzu-Hao, et al.
Publicado: (2020)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis
por: Li, Tzu-Hao, et al.
Publicado: (2016)

Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches
por: Tsai, Yu-Lien, et al.
Publicado: (2020)

Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice
por: Tsai, Hung-Cheng, et al.
Publicado: (2020)

Intestinal SIRT1 Deficiency-Related Intestinal Inflammation and Dysbiosis Aggravate TNFα-Mediated Renal Dysfunction in Cirrhotic Ascitic Mice
por: Chou, Yu-Te, et al.
Publicado: (2021)

Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysis
por: Tsai, Yu-Chi, et al.
Publicado: (2023)

Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study
por: Chang, Te-Sheng, et al.
Publicado: (2021)

CXCR2 inhibition enables NASH-HCC immunotherapy
por: Leslie, Jack, et al.
Publicado: (2022)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
por: Liu, Ta-Wei, et al.
Publicado: (2020)

Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model
por: Su, Yen-Bo, et al.
Publicado: (2018)

Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis
por: Rivas, Gloriany, et al.
Publicado: (2021)

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)
por: Chawla, Kashmira S, et al.
Publicado: (2016)

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan
por: Tsai, Pei-Chien, et al.
Publicado: (2021)

Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway
por: Tai, Yun-Shen, et al.
Publicado: (2021)

High-Throughput Sequencing of Complementarity Determining Region 3 in the Heavy Chain of B-Cell Receptor in Renal Transplant Recipients: A Preliminary Report
por: Wu, Tsai-Hung, et al.
Publicado: (2022)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Correction: SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice
Publicado: (2020)

Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats
por: Liu, Szu-Yu, et al.
Publicado: (2021)

Hemophagocytic Lymphohistiocytosis in Dermatomyositis
por: Liao, Hsien-Tzung, et al.
Publicado: (2019)

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study
por: Tsai, Yu-Fen, et al.
Publicado: (2019)

A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
por: Zhang, Tian-Ying, et al.
Publicado: (2020)

Cytokines and regulatory T cells in ankylosing spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2023)

Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study
por: Theel, Willy B, et al.
Publicado: (2023)

Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study
por: Lin, Ming-Shyan, et al.
Publicado: (2015)

The effect of Sirt1 deficiency on Ca(2+) and Na(+) regulation in mouse ventricular myocytes
por: Yang, Hsiang‐Yu, et al.
Publicado: (2020)

Adiponectin–leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance
por: Lu, Chia-Wen, et al.
Publicado: (2023)

TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients
por: Fan, Wen-Chien, et al.
Publicado: (2016)

Maternal Resveratrol Treatment Re-Programs and Maternal High-Fat Diet-Induced Retroperitoneal Adiposity in Male Offspring
por: Tsai, Ti-An, et al.
Publicado: (2020)

Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats
por: Li, Tzu-Hao, et al.
Publicado: (2016)

Percutaneous catheter drainage versus percutaneous needle aspiration for liver abscess: a systematic review, meta-analysis and trial sequential analysis
por: Lin, Jin-Wei, et al.
Publicado: (2023)

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
por: Liu, Jinkai, et al.
Publicado: (2022)

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
por: Rao, Jianhua, et al.
Publicado: (2022)

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
por: Amin, Neeta B, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
por: Zhang, Chao, et al.
Publicado: (2023)

S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos
por: Wang, Xia, et al.
Publicado: (2023)

Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma
por: Tseng, Yi-Hsin, et al.
Publicado: (2016)

Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort
por: Luo, Laihui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v83ar6b3s02fhl0nkn3fb74lmv